General Growth to become stronger with acquisition of Rouse
450481
General Growth Properties, the company that owns Ala Moana Center, Victoria Ward Ltd., and Hilo&#39;s Prince Kuhio Plaza, stands to gain even more leverage with national retail chains after acquiring the Rouse Co.
157558
New acquisitions and products should increase sales.
769005
General Growth Properties Inc. on  Friday said it would buy Rouse Co. for $7.2 billion, adding  such swank shopping centers as Chicago's Water Tower Place and  Boston's Fanueil Hall to what is already the nation's second  largest mall portfolio.
725994
Research and Markets (http://www.researchandmarkets.com/reports/c46724)  has announced the addition of "Growth  Opportunities in Global Pultrusion Market 2006-2011"  to their offering.
176199
Sink your hooks into powerful growth.
396798
The online retailer continues to accelerate its growth levels.
377694
Is this industry leader an attractive investment?
132865
There's more to growth than just a high growth rate.
622273
WASHINGTON - Rouse Co., the once-visionary real estate firm that founded the city of Columbia, Md., and revitalized Harborplace in Baltimore, is being acquired for $7.2 billion in cash by General Growth Properties, a Chicago-based owner ...
384420
COLUMBIA, Md. Aug. 20, 2004  General Growth Properties Inc., a Chicago-based developer of regional shopping malls, said Friday it will buy the Rouse Co. for about $7.2 billion. The deal will provide it with more leverage in negotiations with top ...
324736
After some key changes, the company may be poised for growth.
643271
he Rouse Company, the mall developer and manager that has helped reshape the nation&#39;s landscape, agreed yesterday to be acquired by General Growth Properties, the big owner of shopping centers, for $7.
690984
If it can keep integrating buys and grow profits, this looks like a company worth holding.
701907
The maker of office furniture generates solid growth.
75091
The world's largest generics maker continues to post strong growth by bedeviling Big Pharma.
2830
Analysts expect continued growth despite a tough environment.
692234
A new acquisition may lead to differentiation.